| Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease M Lundblad, M Andersson, C Winkler, D Kirik, N Wierup, MA Cenci European Journal of Neuroscience 15 (1), 120-132, 2002 | 789 | 2002 |
| Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry S Khatib-Shahidi, M Andersson, JL Herman, TA Gillespie, RM Caprioli Analytical chemistry 78 (18), 6448-6456, 2006 | 595 | 2006 |
| Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry MR Groseclose, M Andersson, WM Hardesty, RM Caprioli Journal of Mass Spectrometry 42 (2), 254-262, 2007 | 441 | 2007 |
| Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of … M Andersson, A Hilbertson, MA Cenci Neurobiology of disease 6 (6), 461-474, 1999 | 410 | 1999 |
| Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction M Andersson, MR Groseclose, AY Deutch, RM Caprioli Nature methods 5 (1), 101-108, 2008 | 306 | 2008 |
| Processing MALDI mass spectra to improve mass spectral direct tissue analysis JL Norris, DS Cornett, JA Mobley, M Andersson, EH Seeley, P Chaurand, ... International journal of mass spectrometry 260 (2-3), 212-221, 2007 | 258 | 2007 |
| A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer DS Cornett, JA Mobley, EC Dias, M Andersson, CL Arteaga, ME Sanders, ... Molecular & Cellular Proteomics 5 (10), 1975-1983, 2006 | 240 | 2006 |
| Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry A Nilsson, TE Fehniger, L Gustavsson, M Andersson, K Kenne, ... PloS one 5 (7), e11411, 2010 | 236 | 2010 |
| Heat stabilization of the tissue proteome: a new technology for improved proteomics M Svensson, M Borén, K Skold, M Fälth, B Sjogren, M Andersson, ... Journal of proteome research 8 (2), 974-981, 2009 | 176 | 2009 |
| cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum M Andersson, C Konradi, MA Cenci Journal of Neuroscience 21 (24), 9930-9943, 2001 | 170 | 2001 |
| Persistent changes in striatal gene expression induced by long‐term l‐DOPA treatment in a rat model of Parkinson's disease JE Westin, M Andersson, M Lundblad, MA Cenci European journal of neuroscience 14 (7), 1171-1176, 2001 | 160 | 2001 |
| Changes in the regional and compartmental distribution of FosB-and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment MA Cenci, A Tranberg, M Andersson, A Hilbertson Neuroscience 94 (2), 515-527, 1999 | 159 | 1999 |
| Time course of striatal ΔFosB‐like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment M Andersson, JE Westin, MA Cenci European journal of neuroscience 17 (3), 661-666, 2003 | 106 | 2003 |
| L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry J Hanrieder, A Ljungdahl, M Fälth, SE Mammo, J Bergquist, M Andersson Molecular & Cellular Proteomics 10 (10), 2011 | 105 | 2011 |
| Quantitative mass spectrometry imaging of small-molecule neurotransmitters in rat brain tissue sections using nanospray desorption electrospray ionization HM Bergman, E Lundin, M Andersson, I Lanekoff Analyst 141 (12), 3686-3695, 2016 | 104 | 2016 |
| Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia PA Johansson, M Andersson, KE Andersson, MA Cenci Neurobiology of disease 8 (2), 220-239, 2001 | 97 | 2001 |
| Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampus O Karlsson, AL Berg, AK Lindström, J Hanrieder, G Arnerup, E Roman, ... Toxicological sciences 130 (2), 391-404, 2012 | 87 | 2012 |
| Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's disease A Ljungdahl, J Hanrieder, M Fälth, J Bergquist, M Andersson PloS one 6 (9), e25653, 2011 | 84 | 2011 |
| MALDI imaging mass spectrometry of neuropeptides in Parkinson's disease J Hanrieder, A Ljungdahl, M Andersson JoVE (Journal of Visualized Experiments), e3445, 2012 | 68 | 2012 |
| MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue J Hanrieder, G Wicher, J Bergquist, M Andersson, Å Fex-Svenningsen Analytical and bioanalytical chemistry 401, 135-147, 2011 | 63 | 2011 |
Jörg HanriederUniversity of Gothenburg, University College LondonVerifierad e-postadress på neuro.gu.se
